tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ZyVersa Therapeutics Stock Approved for OTCQB Listing
PremiumCompany AnnouncementsZyVersa Therapeutics Stock Approved for OTCQB Listing
1M ago
ZyVersa CEO says ‘deeply committed’ to executing with discipline, urgency
Premium
The Fly
ZyVersa CEO says ‘deeply committed’ to executing with discipline, urgency
2M ago
ZyVersa Therapeutics Faces Nasdaq Delisting, Plans Pink Market Move
Premium
Company Announcements
ZyVersa Therapeutics Faces Nasdaq Delisting, Plans Pink Market Move
2M ago
ZyVersa announces first clinical site activation in VAR 200 Phase 2a trial
PremiumThe FlyZyVersa announces first clinical site activation in VAR 200 Phase 2a trial
2M ago
ZyVersa Therapeutics Secures $10M Equity Purchase Agreement
Premium
Company Announcements
ZyVersa Therapeutics Secures $10M Equity Purchase Agreement
2M ago
ZyVersa Therapeutics announcs share purchase agreement for up to $10M
Premium
The Fly
ZyVersa Therapeutics announcs share purchase agreement for up to $10M
2M ago
ZyVersa Therapeutics announces publication of data on inflammasome inhibition
PremiumThe FlyZyVersa Therapeutics announces publication of data on inflammasome inhibition
4M ago
ZyVersa Therapeutics CEO provides update on inflammasome ASC inhibitor IC 100
Premium
The Fly
ZyVersa Therapeutics CEO provides update on inflammasome ASC inhibitor IC 100
5M ago
ZyVersa Therapeutics Reports 2024 Financial Results and Progress
Premium
Company Announcements
ZyVersa Therapeutics Reports 2024 Financial Results and Progress
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100